The medical technology developer received series D funding from investors including existing backer Tencent, pushing its total funding past $120m.

China-based gene-sequencing technology developer Vision Medicals has raised RMB300m ($47m) in a series D round featuring internet and gaming group Tencent, DealStreetAsia reported today, citing a company statement. Private equity firm Boyu Capital also participated in the round, as did CDH Venture and Growth Capital, a vehicle for alternative asset management firm CDH. Founded in…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.